Noninvasive assessment of preclinical atherosclerosis

Vascular Health and Risk Management

Volumn 2, Issue 1, 2006, Pages 19-30

  Lane, Helen A ^a,b   Smith, Jamie C ^a   Davies, J Stephen ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Endothelial function; Vascular risk; Vascular stiffness

Indexed keywords

ANTILIPEMIC AGENT; ANTIOXIDANT; ARGININE; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 8; C REACTIVE PROTEIN; GLYCERYL TRINITRATE; HYDRALAZINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; NORADRENALIN; SALBUTAMOL; TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR;

ANGIOCARDIOGRAPHY; ANGIOGENESIS; ARTERY COMPLIANCE; ARTERY DILATATION; ARTERY INTIMA PROLIFERATION; ARTERY PERMEABILITY; ATHEROSCLEROSIS; BLOOD CLOT LYSIS; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY FLOW; CLINICAL ASSESSMENT; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DRUG ANTAGONISM; DRUG MECHANISM; ELECTROCARDIOGRAM; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVITY; HEART PROTECTION; HUMAN; LEUKOCYTE FUNCTION; LIPID OXIDATION; META ANALYSIS; NON INVASIVE MEASUREMENT; NONHUMAN; PATHOGENESIS; PHOTOELECTRIC PLETHYSMOGRAPHY; PROGNOSIS; PULSE WAVE; REGULATORY MECHANISM; REVIEW; RISK ASSESSMENT; RISK FACTOR; STEM CELL; SYSTEMATIC REVIEW; THROMBOCYTE FUNCTION; TONOMETRY; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD COAGULATION FACTORS; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CORONARY ANGIOGRAPHY; CYTOKINES; ELASTICITY; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; LIPOPROTEINS, LDL; PLETHYSMOGRAPHY; PULSE; REGIONAL BLOOD FLOW; RISK ASSESSMENT; RISK FACTORS; STEM CELLS; TUNICA INTIMA; ULTRASONOGRAPHY, INTERVENTIONAL; VASODILATION;

EID: 33646074295     PISSN: 11766344     EISSN: None     Source Type: Journal    
DOI: 10.2147/vhrm.2006.2.1.19     Document Type: Review

References (160)

1. Aikawa M, Rabkin E, Okada Y, et al. 1998. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilisation. Circulation, 97:2433-44.
2. Anderson TJ, Meredith IT, Yeung AC, et al. 1995. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Eng J Med, 332:488-93.
3. Anderson TJ, Gerhard MD, Meredith IT, et al. 1995. Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol, 75:71B-74B.
4. Anderson TJ, Uehata A, Gerhard MD, et al. 1995. Close relation of endothelial function in the human coronary and peripheral circulation. J Am Coll Cardiol, 26:1235-41.
5. Antony I, Aptecar E, Lerebours G, et al. 1994. Coronary artery constriction caused by the cold pressor test in human hypertension. Hypertension, 24:212-19.
6. Armentano R, Simon A, Levenson J, et al. 1991. Mechanical pressure versus intrinsic effects of hypertension on large arteries in humans. Hypertension, 18:657-64.
7. Arnett DK, Evans GW, Riley WA. 1994. Arterial stiffness: a new cardiovascular risk factor. Am J Epidemiol, 140:669-82.
8. Avolio AP, Chen SG, Wang RP, et al. 1983. Effects of ageing on changing arterial compliance and left ventricular load in a northern Chinese urban community. Circulation, 68:50-8
9. Barth JD. 2004. Carotid intima media thickness and beyond. Curr Drug Targets Cardiovasc Hematol Disord, 4:129-45.
10. Benetos A, Rudnichi A, Safar M, et al. 1998. Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension, 32:560-4.
11. Benetos A, Safar M, Rudnichi A, et al. 1997. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension, 30:1410-15.
12. Berliner J, Navab M, Fogelman A, et al. 1995. Atherosclerosis: basic mechanisms. Circulation, 91:2488-96.
13. Blacher J, Safar ME, Pannier B, et al. 2002. Prognostic significance of arterial stiffness measurements in end-stage renal disease patients. Curr Opin Nephrol Hypertens, 11:629-34.
14. Bortolotto LA, Blacher J, Kondo T, et al. 2000. Assessment of vascular aging and atherosclerosis in hypertensive subjects: second derivative of photophlethysmogram versus pulse wave velocity. Am J Hypertens, 13:165-71.
15. Bots ML, Evans GW, Riley WA, et al. 2003. Carotid intima-media thickness measurements in intervention studies: design options, progression rates, and sample size considerations; a point of view. Stroke, 34: 2985-94.
16. Bots ML, Hoes AW, Koudstaal PJ, et al. 1997. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation, 96:1432-7.
17. Bots ML, Witteman JC, Grobbee DE. 1993. Carotid intima-media wall thickness in elderly women with and without atherosclerosis of the abdominal aorta. Atherosclerosis, 102:99-105.
18. Cardillo C, Kilcoyne CM, Quyyumi AA, et al. 1997. Decreased vasodilator response to isoproterenol during nitric oxide inhibition in humans. Hypertension, 30:918-21.
19. Celermajer DS, Sorensen KE, Gooch V, et al. 1992. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet, 340:1111-15.
20. Chambless LE, Folsom AR, Sharrett AR, et al. 2003. Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study. J Clin Epidemiol, 56:880-90.
21. Chaves PH, Kuller LH, O'Leary DH, et al. 2004. Subclinical cardiovascular disease on older adults: insights from the Cardiovascular Health Study. Am J Geriatr Cardiol, 13:137-51.
22. Chen CH, Nevo E, Fetics B, et al. 1997. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Circulation, 95:1827-36.
23. Chiu YC, Arand PW, Shroff SG, et al. 1991. Determination of pulse wave velocities with computerised algorithms. Am Heart J, 121:1460-70.
24. 2-adrenergic vasodilation in type II diabetes mellitus. J Am Coll Cardiol, 34:2007-14.
25. Cockcroft JR, Wilkinson IB, Webb DJ. 1997. The Trevor Howell Lecture. Age, arterial stiffness and the endothelium. Age Ageing, 26(Suppl 4): 53-60.
26. Cohn J, Finkelstein S, McVeigh G, et al. 1995. Non-invasive pulse wave analysis for the early detection of vascular disease. Hypertension, 26:503-8.
27. Covic A, Goldsmith DJ, Gusbeth-Tatomir P, et al. 2003. Successful renal transplantation decreases aortic stiffness and increases vascular reactivity in dialysis patients. Transplantation, 76:1573-7.
28. Dagres N, Saller B, Haude M, et al. 2004. Insulin sensitivity and coronary vasoreactivity: insulin sensitivity relates to adenosine-stimulated coronary flow response in human subjects. Clin Endocrinol (Oxf), 61:724-31.
29. Dart AM, Lancombe F, Yeoh JK, et al. 1991. Aortic distensibility in patients with isolated hypercholesterolaemia, coronary artery disease, or cardiac transplantation. Lancet, 338:270-3.
30. Davies JI, Struthers A. 2003. Pulse wave analysis and pulse wave velocity: a critical review of their strengths and weaknesses. J Hypertens, 21:463-72.
31. Dawes M, Chowienczyk PJ, Ritter JM. 1997. Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by beta-adrenergic agonists in human forearm. Circulation, 95:2293-7.
32. De Roos NM, Bots ML, Schouten E, et al. 2003. Within subject variability of flow mediated vasodilation of the brachial artery in healthy men and women: implications for experimental studies. Ultrasound Med Biol, 29:401-6.
33. Domanski MJ, Davis BR, Pfeffer MA, et al. 1999. Isolated systolic hypertension: prognostic information provided by pulse pressure. Hypertension, 34:375-80.
34. Esen AM, Barutcu I, Acar M, et al. 2004. Effect of smoking on endothelial function and wall thickness of brachial artery. Circ Res, 68:1123-6.
35. Faulx MD, Wright AT, Hoit BD. 2003. Detection of endothelial dysfunction with brachial artery ultrasound scanning. Am Heart J, 145:943-51.
36. Fetics B, Nevo E, Chen CH, et al. 1999. Parametric model derivation of transfer function for non-invasive estimation of aortic pressure by radial tonometry. IEEE Trans Biomed Eng, 46:698-706.
37. Folsom AR, Rosamond WD, Shahar E, et al. 1999. Prospective study of markers of hemostatic function with risk of ischaemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation, 100:736-42.
38. Franklin SS, Khan SA, Wong ND, et al. 1999. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation, 100:354-60.
39. Franklin SS, Gustin W 4th, Wong ND, et al. 1997. Hemodynamic patterns of age-related changes in blood pressure: The Framingham Heart Study. Circulation, 96:308-15.
40. Frishman WH. 2000. Increased vascular compliance/decreased cardiovascular risk: what the studies tell us. Heart Dis, 2:384-8.
41. Fujiwara S, Emoto M, Komatsu M, et al. 2003. Arterial wall thickness is associated with insulin resistance in type 2 diabetic patients. J Atheroscler Thromb, 10:246-52.
42. Furumoto T, Fujii S, Saito N, et al. 2002. Relationships between brachial artery flow mediated dilation and carotid artery intima-media thickness in patients with suspected coronary artery disease. Jpn Heart J, 43:117-25.
43. Giannattasio C, Mangonic AA, Failla M, et al. 1996. Impaired radial artery compliance in normotensive subjects with familial hypercholesterolemia. Atherosclerosis, 124:249-60.
44. Gollino P, Piscione F, Willerson JT, et al. 1991. Divergent effects of serotonin on coronary artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N Engl J Med, 324:641-8.
45. Goodfellow J, Ramsey MW, Luddington LA, et al. 1996. Endothelium and inelastic arteries: an early marker of vascular dysfunction in noninsulin dependent diabetes. Br Med J, 312:744-5.
46. Groves P, Kurz S, Just H, et al. 1995. Role of endogenous bradykinin in human coronary vasomotor control. Circulation, 92:3424-30.
47. Haydar AA, Covic A, Colhoun H, et al. 2004. Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients. Kidney Int, 65:1790-4.
48. Hayward CS, Kraidly M, Webb CM, et al. 2002. Assessment of endothelial function using peripheral waveform analysis: a clinical application. J Am Coll Cardiol, 40:521-8.
49. Healy B. 1990. Endothelial cell dysfunction: an emerging endocrinopathy linked to coronary disease. J Am Coll Cardiol, 16:357-8.
50. Hill JM, Zalos G, Halcox JP, et al. 2003. Circulating endothelial progenitor cells, vascular function and cardiovascular risk. N Eng J Med, 348: 593-600.
51. Hodgson JM, Marshall JJ. 1989. Direct vasoconstriction and endothelium-dependent vasodilation: mechanisms of acetylcholine effects on coronary flow and arterial diameter in patients with nonstenotic coronary arteries. Circulation, 79:1043-51.
52. Hodis HN, Mack WJ, LaBree L, et al. 1998. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med, 128:262-9.
53. Hoeks A, Brands P, Smeets F, et al. 1990. Assessment of the distensibility of superficial arteries. Ultrasound Med Biol, 16:121-8.
54. Holay MP, Paunikar NP, Joshi PP, et al. 2004. Effect of passive smoking on endothelial function in healthy adults. J Assoc Physicians India, 52:114-17.
55. Igarashi Y, Chikamori T, Tomiyama H, et al. 2005. Diagnostic value of simultaneous brachial and ankle blood pressure measurements for the extent and severity of coronary artery disease as assessed by myocardial perfusion imaging. Circ J, 69:237-42.
56. Iglesias del Sol A, Bots ML, Grobbee DE, et al. 2002. Carotid intima-media thickness at different sites: relation to incident myocardial infarction; The Rotterdam Study. Eur Heart J, 23:916-18.
57. Jadhav UM, Kadam NN. 2002. Association of microalbuminuria with carotid intima-media thickness and coronary artery disease - a cross sectional study in Western India. 50:1124-9.
58. Jansson JH, Nilsson TK, Johnson O. 1991. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J, 66:351-5.
59. Kannam JP, Levy D, Larson M, et al. 1994. Short stature and risk for mortality and cardiovascular disease events. The Framingham Heart Study. Circulation, 90:2241-7.
60. Kannell WB, Wolf PA, McGee DL, et al. 1981. Systolic blood pressure, arterial rigidity, and risk of stroke. JAMA, 245:1225-9.
61. Karamanoglu M, O'Rourke MF, Avolio AP, et al. 1993. An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J, 14:160-7.
62. Katayama Y, Shige H, Yamamoto A, et al. 2004. Oral vitamin C ameliorates smoking-induced arterial wall stiffness in healthy volunteers. J Atheroscler Thromb, 11:354-7.
63. Klemsdal TO, Andersson TL, Matz J, et al. 1994. Vitamin E restores endothelium dependent vasodilatation in cholesterol fed rabbits: in vivo measurements by photophlesymography. Cardiovasc Res, 28:1397-1402.
64. Koller A. 2002. Signaling pathways of mechanotransduction in arteriolar endothelium and smooth muscle cells in hypertension. Microcirculation, 9:277-94.
65. Kuvin JT, Karas RH. 2003. Clinical utility of endothelial function testing: ready for prime time? Circulation, 107:3243-7.
66. Lakatta EG. 1991. Similar myocardial effects of aging and hypertension. Eur Heart J, 11:29-38.
67. Latson TW, Hunter WC, Katoh N, et al. 1988. Effect of nitroglycerin on aortic impedance, diameter, and pulse-wave velocity. Circ Res, 62: 884-90.
68. Laurent S, Boutouyrie P. 2005. Arterial stiffness and stroke in hypertension; therapeutic implications for stroke prevention. CNS Drugs, 19:1-11.
69. Laurent S, Boutouyrie P, Asmar R, et al. 2001. Aortic stiffness is an independent predictor of all-cause mortality in hypertensive patients. Hypertension, 37:1236-41.
70. Lefroy DC, Crake T, Uren NG, et al. 1993. Effect of inhibition of NO synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Circulation, 88:43-54.
71. Lehmann ED, Riley WA, Clarkson P, et al. 1997. Non-invasive assessment of cardiovascular disease in diabetes mellitus. Lancet, 350(Suppl 1): SI14-19.
72. Levy D, Garrison R, Savage DD, et al. 1990. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med, 332:1561-6.
73. Li JJ, Fang CH. 2004. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. Med Hypotheses, 62:499-506.
74. Ludmer PL, Selwyn AP, Shook TL, et al. 1986. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med, 315:1046-51.
75. Lund F. 1986. Digital pulse plethysmography (DPG) in studies of the hemodynamic responses to nitrates - a survey of recording methods and principles of analysis. Acta Pharmacol Toxicol (Copenh), 59(Suppl 6):79-96.
76. Macioch JE, Katsamakis CD, Robin J, et al. 2004. Effect of contrast enhancement on measurement of carotid artery intimal medial thickness. Vasc Med, 9:7-12.
77. MacMahon S, Peto R, Cutler J, et al. 1990. Blood pressure, stroke and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for regression dilution bias. Lancet, 335:765-74.
78. Mannucci PM. 1998. von Willebrand factor: a marker of endothelial damage? Arteriscler Thromb Vasc Biol, 18:1359-62.
79. Martin RP, Lerakis S. 2004. Contrast for vascular imaging. Cardiol Clin, 22:313-20.
80. Maseri A, L'Abbate A, Baroldi G, et al. 1978. Coronary vasospasm as a possible cause of myocardial infarction: a conclusion derived from the study of "preinfarction" angina. N Eng J Med, 229:1271-7.
81. Matsuo S, Matsumoto T, Takashima H, et al. 2004. The relationship between flow mediated brachial artery vasodilation and coronary vasomotor responses to bradykinin: comparison with those to acetylcholine. J Cardiovasc Pharmacol, 44:164-70.
82. McGrath BP, Liang YL, Kotsopoulos D, et al. 2001. Impact of physical and physiological factors on arterial function. Clin Exp Pharmacol Physiol, 28:1104-7.
83. McNeill AM, Rosamond WD, Girman CJ et al. 2004. Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (The ARIC study). Am J Cardiol, 94: 1249-54.
84. McVeigh GE, Brennan GM, Johnston GD, et al. 1992. Impaired endothelium-dependent and independent vasodilatation in patients with type 2 (non-insulin dependent) diabetes mellitus. Diabetologia, 35:771-6.
85. McVeigh GE, Burns DE, Finkelstein SM, et al. 1991. Reduced vascular compliance as a marker for essential hypertension. Am J Hypertens, 4:245-51.
86. Meaume S, Benetos A, Henry OF, et al. 2001. Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 yrs of age. Arterioscler Thromb Vasc Biol, 21:2046-50.
87. Miller JA, Lever AF, Burke V. 1999. Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial. J Hypertens, 17:1065-72.
88. Millasseau SC, Stewart AD, Patel SJ, et al. 2005. Evaluation of carotid-femoral pulse wave velocity: influence of timing algorithm and heart rate. Hypertension, 45:222-6.
89. Millasseau SC, Kelly RP, Ritter JM, et al. 2002. Determination of age-related increases in large artery stiffness by digital pulse contour analysis. Clin Sci (Lond), 103: 371-7.
90. Morikawa Y. 1967. Characteristic pulse wave caused by organic nitrates. Nature, 213:841-2.
91. + current. Am J Physiol Heart Circ Physiol, 288:H1233-41.
92. Nichols WW. 2005. Clinical measurement of arterial stiffness obtained from non-invasive pressure waveforms. Am J Hypertens, 18:3-10.
93. Nichols WW, O'Rourke MF. 1998. McDonald's blood flow in arteries: theoretical, experimental and clinical principles. London: Edward Arnold.
94. Nichols WW, O'Rourke MF. 2005. McDonald's blood flow in arteries: theoretical, experimental and clinical principles. 5th Ed. London: Edward Arnold.
95. Nili N, Zhang M, Strauss BH, et al. 2002. Biochemical analysis of collagen and elastin synthesis in the balloon injured rat carotid artery. Cardiovasc Pathol, 11:272-6.
96. Nitenberg A, Paycha F, Ledoux S, et al. 1998. Coronary artery responses to physical stimuli are improved by deferoxamine but not by L-arginine in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors. Circulation, 97: 736-43.
97. Norata GD, Tonti L, Roma P, et al. 2002. Apoptosis and proliferation of endothelial cells in early atherosclerotic lesions: possible role of oxidised LDL. Nutr Metab Cardiovasc Dis, 12:297-305.
98. Ohshita K, Yamane K, Ishida K, et al. 2004. Post-challenge hyperglycaemia is an independent risk factor for arterial stiffness in Japanese men. Diab Med, 21:636-9.
99. O'Leary DH, Polak JF, Kronmal RA, et al. 1999. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Group. N Eng J Med, 340:14-22.
100. Oliver J, Webb D. 2003. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol, 23: 554-66.
101. O'Rourke MF, Gallagher DE. 1996. Pulse wave analysis. J Hypertens, 14(Suppl 5):147-57.
102. O'Rourke MF, Kelly RP. 1993. Wave reflection in the systemic circulation and its implications in ventricular function. J Hypertens, 11:327-37.
103. O'Rourke MF. 1976. Pulsatile arterial haemodynamics in hypertension. Aust N Z J Med, 6(S2):40-8.
104. Parhami F, Fang ZT, Fogelman AM, et al. 1993. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J Clin Invest, 92:471-8.
105. Pauca AL, Wallenhaupt ST, Kon ND, et al. 1992. Does radial artery pressure accurately reflect aortic pressure? Chest, 102:1193-8.
106. Pearson AC, Guo R, Orsinelli DA, et al. 1994. Transesophageal echocardiographic assessment of the effects of age, gender, and hypertension on thoracic aortic wall size, thickness, and stiffness. Am Heart J, 128:344-51.
107. Philippe F, Chemaly E, Blacher J, et al. 2002. Aortic pulse pressure and the extent of coronary artery disease in percutaneous transluminal coronary angioplasty candidates. Am J Hypertens, 15:672-7.
108. Ramsey M, Goodfellow J, Jones C, et al. 1995. Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation, 92:3212-19.
109. Ridker PM, Cannon CP, Morrow D, et al. 2005. C-reactive protein levels and outcomes after statin therapy. N Engl J Med, 352:73-5
110. Ridker PM. 2002. High-sensitive C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation, 103:1813-18.
111. Ridker PM, Stampfer MJ, Rifai N. 2001. Novel risk factors for systemic atherosclerosis; a comparison of C-reactive protein, fibrinogen, hornocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA, 285:2481-5.
112. Ross R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 362:801-9.
113. Salomaa V, Riley W, Kark J, et al. 1995. Non-insulin dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation, 91:1432-43.
114. Salonen JT, Salonen R. 1993. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation, 87:II56-65.
115. Schachinger V, Britten MB, Zeiher AM. 2000. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation, 101:1899-1906.
116. Schini-Kerth VB. 1999. Dual effects of insulin-like growth factor-I on the constitutive and inducible (NO) synthase-dependent formation of NO in vascular cells. J Endocrinol Invest, 22(5 Suppl):82-8.
117. Schmidt-Lucke C, Rossig L, Fichtlscherer S, et al. 2005. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation, 111:2981-7.
118. Sengstock DM, Vaitkevicius PV, Supiano MA. 2005. Arterial stiffness is related to insulin resistance in nondiabetic hypertensive older adults; J Clin Endocrinol Metab, 90:2823-7.
119. Singh TP, Groehn H, Kazmers A. 2003. Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus. J Am Coll Cardiol, 41:661-5.
120. Silva GV, Litovsky S, Assad JA, et al. 2005. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischaemia model. Circulation, 111:150-6.
121. Smith A, Karalliedde J, De Angelis L, et al. 2005. Aortic pulse wave velocity and albuminuria in patients with type 2 diabetes. J Am Soc Nephrol, 16:1069-75.
122. Smith JC, Evans LM, Wilkinson I, et al. 2002. Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study. Clin Endocrinol (Oxf), 56:493-501.
123. Smith JC, Lane HA, Lewis J, et al. 2003. Endothelial function and coagulant factors in growth hormone-treated hypopituitary adults receiving desmopressin. J Clin Endocrinol Metab, 88:2152-6.
124. Suh HS, Park YW, Kang JH, et al. 2005. Vascular endothelial dysfunction tested by blunted response to endothelium-dependent vasodilation by salbutamol and its related factors in uncomplicated pre-menopausal obese women. Int J Obes (Lond), 29:217-22.
125. Sutton-Tyrrell K, Najjar SS, Boudreeau RM, et al. 2005. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation, 111:3384-90.
126. Szmitko PE, Wang CH, Weisel RD, et al. 2003. New markers of inflammation and endothelial cell activation. Circulation, 108: 1917-23.
127. Takazawa K, Tanaka N, Fujita M, et al. 1998. Assessment of vasoactive agents and vascular ageing by the second derivative of photophlesysmograph waveform. Hypertension, 32:365-70.
128. ter Avest E, Holewijn S, Stalenhoef AF, et al. 2005. Variation in non-invasive measurements of vascular function in healthy volunteers during daytime. Clin Sci, 108:425-31.
129. Thomas GN, Chook P, Oiao M, et al. 2004. Deleterious impact of "high normal" glucose levels and other metabolic syndrome components on arterial endothelial function and intima-media thickness in apparently healthy Chinese subjects: the CATHAY study. Arteriscler Thromb Vasc Biol, 24:739-43.
130. Thompson SG, Kienast J, Pyke SD, et al. 1995. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Eng J Med, 332:635-41.
131. Tio RA, Monnin SH, Amoroso G, et al. 2002. Safety evaluation of routine intracoronary acetylcholine infusion in patients undergoing a first diagnostic coronary angiogram. J Investig Med, 50:133-9.
132. Treasure CB, Klein JL, Weintraub WS, et al. 1995. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med, 332:481-7.
133. Tsimikas S, Bergmark C, Beyer RW, et al. 2003. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. J Am Coll Cardiol, 41: 360-70.
134. Tsimikas S, Witztum J. 2001. Measuring circulating oxidized LDL to evaluate coronary risk. Circulation, 103:1930-2.
135. Tsuchiya M, Suzuki E, Egawa K, et al. 2004. Stiffness and impaired blood flow in lower-leg arteries are associated with severity of coronary artery calcification among asymptomatic type 2 diabetic patients. Diabetes Care, 27:2409-15.
136. Vane JR, Anggard EE, Botting RM. 1990. Regulatory functions of the vascular endothelium. N Engl J Med, 323:27-36.
137. Vanhoutte PM. 1989. Endothelium and control of vascular function. Hypertension, 13:658-67.
138. Vasa M, Fichtlscherer S, Aicher A, et al. 2001. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res, 89:E1-7.
139. Verma S, Wang CH, Lonn E, et al. 2004. Cross-sectional evaluation of brachial artery blood flow-mediated dilatation and C-rective protein in healthy individuals. Eur Heart J, 25:1754-60.
140. Verma S, Wang CH, Li SH, et al. 2002. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation, 106:913-19.
141. Verma S, Li SH, Badiwala MV, et al. 2002. Endothelin antagonism and interleukin-6 inhibition attenuate the pro-atherogenic effects of C-reactive protein. Circulation, 105:1890-6.
142. Vita JA, Keaney JF Jr, Larson MG, et al. 2004. Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study. Circulation; 110:3604-9.
143. Vogel RA, Corretti MC. 1998. Estrogens, progestins, and heart disease: can endothelial function divine the benefit? Circulation, 97:1223-6.
144. Wahlqvist M, Lo C, Myers K, et al. 1988. Putative determinants of arterial wall compliance in NIDDM. Diabetes Care, 11:787-90.
145. Watson AD, Leitinger N, Navab M, et al. 1997. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem, 23:13597-607.
146. Wang CH, Li SH, Weisel RD, et al. 2003. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation, 107:1783-90.
147. Wendelhag I, Wiklund O, Wikstrand J. 1992. Arterial wall thickness in familial hypercholesterolemia. Ultrasound measurement of intima-media thickness in the common carotid artery. Arterioscler Thromb, 12:70-7.
148. Widlansky ME, Gokce N, Keaney Jr JF, et al. 2003. The clinical implications of endothelial dysfunction. J Am Coll Cardiol, 42: 1149-60.
149. Wilhelmsen L. Svardsudd K, Korsan-Bengtsen K, et al. 1984. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med, 311:501-5.
150. Williams IL, Wheatcroft SB, Shah AM, et al. 2002. Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese individuals. Int J Obes Relat Metab Disord, 26:754-64.
151. Williams SB, Cusco JA, Roddy MA, et al. 1996. Impaired nitric oxide-mediated vasodilatation in patients with non-insulin dependent diabetes mellitus. J Am Coll Cardiol, 27:567-73.
152. Wilkinson IB, Hall IR, McCallum H, et al. 2002. Pulse wave analysis: clinical evaluation of a non-invasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol, 22: 147-52.
153. Wilkinson IB, MacCallum H, Flint L, et al 2000. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol, 525:263-80.
154. Wilkinson IB, McEniery CM. 2004. Arterial stiffness, endothelial function and novel pharmacological approaches. Clin Exp Pharmacol Physiol, 31:795-9.
155. Wilkinson IB, Mohammad NH, Tyrrell S, et al. 2002. Heart rate dependency of pulse pressure amplification and arterial stiffness. Am J Hypertens, 15:24-30.
156. Wilkinson IB, Prasad K, Hall IR, et al. 2002. Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia. J Am Coll Cardiol, 39:1005-11.
157. Wilson AM, O'Neal D, Nelson CL, et al. 2004. Comparison of arterial assessments in low and high vascular disease risk groups. Am J Hypertens, 17:285-91.
158. Yeung AC, Vekshtein VI, Krantz DS, et al. 1991. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med, 325:1551-6.
159. Yildiz A, Oflaz H, Pusuroglu H, et al. 2003. Left ventricular hypertrophy and endothelial dysfunction in chronic hemodialysis patients. Am J Kidney Dis, 41:616-23.
160. Zeiher AM, Drexler H, Wollschlager H, et al. 1991. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation, 83: 391-401.